CAS 80573-04-2 – 5-((4-((2-Carboxyethyl)carbamoyl)… | In Stock

CAS No.

80573-04-2

MDL No.

MFCD00868204

C₁₇H₁₅N₃O₆

357.32

InChI Key

IPOKCKJONYRRHP-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability
50 mg	98+%	$156	In Stock
100 mg	98+%	$231	In Stock
250 mg	98+%	$574	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

50 mg

98+%

$156

In Stock

100 mg

98+%

$231

In Stock

250 mg

98+%

$574

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

Balsalazide is a monohydroxybenzoic acid composed of 5-aminosalicylic acid (mesalazine) linked to 4-aminobenzoyl-beta-alanine via an azo bond. It functions as a prodrug, a non-steroidal anti-inflammatory drug, an anti-ulcer agent, and a gastrointestinal medication. It is the conjugate acid of balsalazide(2-).

CAS No.	80573-04-2
Product Name	5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acid

Biological Targets

PPARG·ALOX5·PTGS2·PTGS1

Associated Conditions

ulcerative colitis·inflammatory bowel disease

* The information provided here is compiled from public sources and is for reference only.

5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acid

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acid

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

Balsalazide disodium.

A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis.

A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis.

New developments in the treatment of inflammatory bowel disease.

Documentation

Similar Products

Olsalazine